EL.En. S.p.A. engages in the research and development, manufacture, distribution, and sale of laser systems in Europe and internationally.
Price History & Performance
|Historical stock prices|
|Current Share Price||€17.88|
|52 Week High||€4.36|
|52 Week Low||€18.20|
|1 Month Change||20.16%|
|3 Month Change||58.76%|
|1 Year Change||223.62%|
|3 Year Change||318.98%|
|5 Year Change||240.57%|
|Change since IPO||1,112.72%|
Recent News & Updates
Is EL.En. S.p.A. (BIT:ELN) Worth €17.1 Based On Its Intrinsic Value?
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of EL.En. S.p.A...
Is Now The Time To Put EL.En (BIT:ELN) On Your Watchlist?
Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...
Is EL.En (BIT:ELN) Using Too Much Debt?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Returns At EL.En (BIT:ELN) Appear To Be Weighed Down
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a proven...
|ELN||IT Medical Equipment||IT Market|
Return vs Industry: ELN exceeded the Italian Medical Equipment industry which returned 28% over the past year.
Return vs Market: ELN exceeded the Italian Market which returned 37.4% over the past year.
Stable Share Price: ELN is more volatile than 75% of Italian stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: ELN's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of Italian stocks.
About the Company
EL.En. S.p.A. engages in the research and development, manufacture, distribution, and sale of laser systems in Europe and internationally. The company offers medical laser equipment for use in the fields of physiotherapy, orthopedics, traumatology, rheumatology, dermatology, sports and rehabilitative medicines, surgery, aesthetics, and art; and laser sources and systems for cutting, welding, marking, and engraving on countless materials.
EL.En Fundamentals Summary
|ELN fundamental statistics|
Is ELN overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|ELN income statement (TTM)|
|Cost of Revenue||€343.95m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
Nov 12, 2021
|Earnings per share (EPS)||0.46|
|Net Profit Margin||6.99%|
How did ELN perform over the long term?See historical performance and comparison
0.6%Current Dividend Yield
Is EL.En undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: ELN (€17.88) is trading above our estimate of fair value (€12.9)
Significantly Below Fair Value: ELN is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: ELN is poor value based on its PE Ratio (39.3x) compared to the European Medical Equipment industry average (38.9x).
PE vs Market: ELN is poor value based on its PE Ratio (39.3x) compared to the Italian market (19.6x).
Price to Earnings Growth Ratio
PEG Ratio: ELN is poor value based on its PEG Ratio (3.1x)
Price to Book Ratio
PB vs Industry: ELN is overvalued based on its PB Ratio (5.8x) compared to the XE Medical Equipment industry average (4.9x).
How is EL.En forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ELN's forecast earnings growth (12.8% per year) is above the savings rate (1.8%).
Earnings vs Market: ELN's earnings (12.8% per year) are forecast to grow faster than the Italian market (11.6% per year).
High Growth Earnings: ELN's earnings are forecast to grow, but not significantly.
Revenue vs Market: ELN's revenue (9.2% per year) is forecast to grow faster than the Italian market (2.1% per year).
High Growth Revenue: ELN's revenue (9.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ELN's Return on Equity is forecast to be low in 3 years time (17.7%).
How has EL.En performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ELN has high quality earnings.
Growing Profit Margin: ELN's current net profit margins (7%) are higher than last year (5.9%).
Past Earnings Growth Analysis
Earnings Trend: ELN's earnings have declined by 2.2% per year over the past 5 years.
Accelerating Growth: ELN's earnings growth over the past year (63.6%) exceeds its 5-year average (-2.2% per year).
Earnings vs Industry: ELN earnings growth over the past year (63.6%) underperformed the Medical Equipment industry 63.6%.
Return on Equity
High ROE: ELN's Return on Equity (15.6%) is considered low.
How is EL.En's financial position?
Financial Position Analysis
Short Term Liabilities: ELN's short term assets (€438.8M) exceed its short term liabilities (€251.8M).
Long Term Liabilities: ELN's short term assets (€438.8M) exceed its long term liabilities (€51.6M).
Debt to Equity History and Analysis
Debt Level: ELN's debt to equity ratio (16.1%) is considered satisfactory.
Reducing Debt: ELN's debt to equity ratio has increased from 6.3% to 16.1% over the past 5 years.
Debt Coverage: ELN's debt is well covered by operating cash flow (198.5%).
Interest Coverage: ELN earns more interest than it pays, so coverage of interest payments is not a concern.
What is EL.En current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: ELN's dividend (0.56%) isn’t notable compared to the bottom 25% of dividend payers in the Italian market (1.01%).
High Dividend: ELN's dividend (0.56%) is low compared to the top 25% of dividend payers in the Italian market (3.48%).
Stability and Growth of Payments
Stable Dividend: ELN's dividend payments have been volatile in the past 10 years.
Growing Dividend: ELN's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its low payout ratio (21.8%), ELN's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: ELN's dividends in 3 years are forecast to be well covered by earnings (25.7% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
EL.En has no CEO, or we have no data on them.
Experienced Board: ELN's board of directors are seasoned and experienced ( 21.8 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
EL.En. S.p.A.'s employee growth, exchange listings and data sources
- Name: EL.En. S.p.A.
- Ticker: ELN
- Exchange: BIT
- Founded: 1981
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: €1.426b
- Shares outstanding: 79.77m
- Website: https://www.elengroup.com
Number of Employees
- EL.En. S.p.A.
- Via Baldanzese 17
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/21 20:58|
|End of Day Share Price||2021/10/21 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.